Review
Sep 2026
Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies.
It is concluded that access to long-term care plans is highly heterogeneous, with insufficient adaptation to the specific needs of haematological malignancy survivors treated curatively or non-curatively, and it is proposed that clinical trials should include extended follow-up, direct patient reporting, and innovative...
T. Wästerlid, B. Valcárcel, Diana Presno et al.
· The Lancet Haematology · 2 citations